tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Jonathan Yon - 2 which are a Hold (40%), 3 which are a Buy (60%)
Analyst Jonathan Yon works at CREDIT SUISSE and is covering the Healthcare sector with 10 price targets and ratings displayed on 2 stocks.
Jonathan Yon's average stock forecast success ratio is 25% with an average time for price targets to be met of 35 days.
Most recent stock forecast was given on MD, MEDNAX at 22-Feb-2023.
Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS) at 1/7/2022. The price target of $3.5 was fulfilled within 70 days with a profit of $0.34 (10.76%) receiving and performance score of 1.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
3
$1.88 (167.86%)
7
6 months 21 days ago
0/3 (0%)
$3.34 (176.76%)
Sell
1.25
$0.13 (11.61%)
3
6 months 21 days ago
2/3 (66.67%)
$0.85 (22.03%)
74
Hold
3
10 months 11 days ago
3/4 (75%)
$2.12 (18.76%)
44
Hold
1.5
$0.38 (33.93%)
3
10 months 19 days ago
4/4 (100%)
$0.26 (12.30%)
36
Hold
3
$1.88 (167.86%)
7
1 years 7 months 24 days ago
2/2 (100%)
$-0.57 (-0.43%)
51
What Year was the first public recommendation made by Jonathan Yon?
